Literature DB >> 19656282

Molecular basis of thrombomodulin activation of slow thrombin.

T E Adams1, W Li, J A Huntington.   

Abstract

BACKGROUND: Coagulation is a highly regulated process where the ability to prevent blood loss after injury is balanced against the maintenance of blood fluidity. Thrombin is at the center of this balancing act. It is the critical enzyme for producing and stabilizing a clot, but when complexed with thrombomodulin (TM) it is converted to a powerful anticoagulant. Another cofactor that may play a role in determining thrombin function is the monovalent cation Na(+). Its apparent affinity suggests that half of the thrombin generated is in a Na(+)-free 'slow' state and half is in a Na(+)-coordinated 'fast' state. While slow thrombin is a poor procoagulant enzyme, when complexed to TM it is an effective anticoagulant.
METHODS: To better understand this molecular transformation we solved a 2.4 A structure of thrombin complexed with EGF domains 4-6 of TM in the absence of Na(+) and other cofactors or inhibitors.
RESULTS: We find that TM binds as previously observed, and that the thrombin component resembles structures of the fast form. The Na(+) binding loop is observed in a conformation identical to the Na(+)-bound form, with conserved water molecules compensating for the missing ion. Using the fluorescent probe p-aminobenzamidine we show that activation of slow thrombin by TM principally involves the opening of the primary specificity pocket.
CONCLUSIONS: These data show that TM binding alters the conformation of thrombin in a similar manner as Na(+) coordination, resulting in an ordering of the Na(+) binding loop and an opening of the adjacent S1 pocket. We conclude that other, more subtle subsite changes are unlikely to influence thrombin specificity toward macromolecular substrates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656282      PMCID: PMC2844540          DOI: 10.1111/j.1538-7836.2009.03563.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  50 in total

1.  Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.

Authors:  T Myles; B F Le Bonniec; A Betz; S R Stone
Journal:  Biochemistry       Date:  2001-04-24       Impact factor: 3.162

Review 2.  Regulation of blood coagulation.

Authors:  C T Esmon
Journal:  Biochim Biophys Acta       Date:  2000-03-07

3.  Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.

Authors:  P Fuentes-Prior; Y Iwanaga; R Huber; R Pagila; G Rumennik; M Seto; J Morser; D R Light; W Bode
Journal:  Nature       Date:  2000-03-30       Impact factor: 49.962

4.  Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism.

Authors:  Trevor P Baglin; Robin W Carrell; Frank C Church; Charles T Esmon; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

5.  Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin.

Authors:  Alireza R Rezaie; Likui Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

6.  The molecular basis of thrombin allostery revealed by a 1.8 A structure of the "slow" form.

Authors:  James A Huntington; Charles T Esmon
Journal:  Structure       Date:  2003-04       Impact factor: 5.006

Review 7.  The integration of macromolecular diffraction data.

Authors:  Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

8.  Crystal structure of wild-type human thrombin in the Na+-free state.

Authors:  Daniel J D Johnson; Ty E Adams; Wei Li; James A Huntington
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

Review 9.  How Na+ activates thrombin--a review of the functional and structural data.

Authors:  James A Huntington
Journal:  Biol Chem       Date:  2008-08       Impact factor: 3.915

10.  Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery.

Authors:  Wendy J Carter; Timothy Myles; Craig S Gibbs; Lawrence L Leung; James A Huntington
Journal:  J Biol Chem       Date:  2004-04-09       Impact factor: 5.157

View more
  12 in total

1.  Exposure of R169 controls protein C activation and autoactivation.

Authors:  Nicola Pozzi; Sergio Barranco-Medina; Zhiwei Chen; Enrico Di Cera
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

2.  Why Ser and not Thr brokers catalysis in the trypsin fold.

Authors:  Leslie A Pelc; Zhiwei Chen; David W Gohara; Austin D Vogt; Nicola Pozzi; Enrico Di Cera
Journal:  Biochemistry       Date:  2015-02-11       Impact factor: 3.162

3.  Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa.

Authors:  Austin D Vogt; Alaji Bah; Enrico Di Cera
Journal:  J Phys Chem B       Date:  2010-09-02       Impact factor: 2.991

4.  NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation.

Authors:  Bernhard C Lechtenberg; Daniel J D Johnson; Stefan M V Freund; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-21       Impact factor: 11.205

5.  Ligand binding shuttles thrombin along a continuum of zymogen- and proteinase-like states.

Authors:  Parvathi Kamath; James A Huntington; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2010-07-16       Impact factor: 5.157

6.  Bio-inspired liposomal thrombomodulin conjugate through bio-orthogonal chemistry.

Authors:  Hailong Zhang; Jacob Weingart; Rui Jiang; Jianhao Peng; Qingyu Wu; Xue-Long Sun
Journal:  Bioconjug Chem       Date:  2013-03-15       Impact factor: 4.774

7.  Ligand binding to anion-binding exosites regulates conformational properties of thrombin.

Authors:  Marina V Malovichko; T Michael Sabo; Muriel C Maurer
Journal:  J Biol Chem       Date:  2013-02-01       Impact factor: 5.157

8.  Thrombin a-chain: activation remnant or allosteric effector?

Authors:  Isis S R Carter; Amanda L Vanden Hoek; Edward L G Pryzdial; Ross T A Macgillivray
Journal:  Thrombosis       Date:  2010-12-09

9.  Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function.

Authors:  Calvin H Yeh; Alan R Stafford; Beverly A Leslie; James C Fredenburgh; Jeffrey I Weitz
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

10.  Rational Design of Protein C Activators.

Authors:  Sergio Barranco-Medina; Mary Murphy; Leslie Pelc; Zhiwei Chen; Enrico Di Cera; Nicola Pozzi
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.